© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
688153 |
As an accredited 1-(4-Bromophenyl)Piperazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 1-(4-Bromophenyl)Piperazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone who’s ever set foot in a chemical research lab will notice how some compounds seem to pop up everywhere. 1-(4-Bromophenyl)Piperazine, often called 4-BP or para-bromophenylpiperazine among chemists, fits squarely into that camp. You don’t need to dig deep before finding it in pharmaceutical development, organic synthesis, and even on the workbenches of those developing new specialty materials. I came across this compound for the first time during a graduate project focused on screening serotonin receptor ligands. The distinctive profile of 1-(4-bromophenyl)piperazine proved especially valuable—its selective activity in receptor binding assays opens doors for targeted research and early-phase innovation.
Plenty of chemicals promise the moon but deliver little. With 1-(4-Bromophenyl)Piperazine, a different picture emerges. The molecular structure—C10H13BrN2—brings together a brominated aromatic ring joined to a piperazine core. That single change, swapping a hydrogen on the phenyl ring with a bromine atom, sets this molecule apart from other derivatives. It offers reactivity hard to match with unsubstituted piperazine or other halogenated analogs. In hands-on research, that bromine opens up a toolkit of reactions, especially for anyone who needs to build on it through Suzuki, Heck, or Buchwald-Hartwig coupling. Compared to its close cousin, 1-phenylpiperazine, the added bromine acts like a built-in handle, making it much more versatile for those working in medicinal chemistry.
Trying to spot the standout quality of 1-(4-Bromophenyl)Piperazine might sound tricky without looking at the specifics. I’ve seen labs wrestle with unreliable intermediates or face headaches with purification. Here, high-purity grades—typically above 98%—cut through many of those problems. This minimizes the risk of side-products muddying up reaction profiles or creating issues down the line. From personal experience, getting a consistent, crystalline material instead of an unmanageable sticky mess keeps experiments moving and data trustworthy. Not every batch of a specialty chemical delivers the same measurable quality, so reliable purity goes a long way in daily lab work.
Unlike some compounds that demand awkward storage or shelf-life worries, this piperazine derivative generally resists decomposition under standard conditions. Simple protection from moisture and direct sunlight tends to do the trick. Each time busy labs revisit this compound, I hear fewer complaints about breakdown or impurities. Such stability reduces wasted time and money, both of which remain in short supply in most research outfits. Reliable inventory means less second-guessing for chemists, especially when deadlines are tight or budgets are limited.
Synthetic chemistry relies on smart intermediates—those compounds that bridge the gap between raw materials and finished products. 1-(4-Bromophenyl)Piperazine keeps popping up in the literature for good reason. Medicinal chemists use it as a building block for designing new CNS-active agents. When I worked in a neuropharmacology group, common protocols involved converting this molecule into more complex ligands for serotonin receptors. The selectivity profile of the para-bromo substitution proved just right for tuning biological activity, helping my team pursue leads with stronger or more targeted action.
It doesn’t end with neuropharmacology. The same atom arrangement opens up further uses: 1-(4-Bromophenyl)Piperazine serves as a scaffold for exploring derivatives in oncological research, antimicrobial drug discovery, and even agricultural chemicals. Each field draws on the molecule’s adaptability. Researchers seeking new kinase inhibitors or trying to generate smart crop protection agents keep drawing from the chemistry of this compound. More than one collaborator has commented to me that they turn back to this brominated piperazine whenever an aromatic halide is needed, instead of making do with less reliable intermediates.
For those outside the medicinal world, the molecule offers a springboard for functional materials. Polymers, dyes, and specialty coatings all rely on well-behaved starting points. The para-bromo group allows for efficient installation into more complex ring systems or linear frameworks. In a materials lab, an old colleague once shared that the predictably clean reactions using this compound kept their projects moving forward—all while avoiding frequent column chromatography or expensive purification steps.
Piperazine by itself hardly turns heads—it’s commonplace and cheap. Start swapping atoms on the aromatic ring, though, and the chemistry changes fast. 1-(4-Bromophenyl)Piperazine competes with related compounds like 1-phenylpiperazine, 1-(2-chlorophenyl)piperazine, and even 1-(3-trifluoromethylphenyl)piperazine. In side-by-side runs, the para-bromo substitution provides advantages in specific coupling reactions. For cross-coupling, bromine represents a sweet spot: less reactive than iodine (meaning fewer side-reactions), but much easier to handle than chlorine (which sometimes just won’t react at all).
Some may argue that other halogenated derivatives work just as well, and in isolated cases that holds true. My time working with 2-chloro analogs, for instance, raised more than a few headaches—lower yield, sluggish conversion, and unpredictable by-products. With this para-bromo version, both reactivity and selectivity improve, which explains its repeat appearances in published literature. For large-scale projects, the operational simplicity carries weight: reactions proceed at milder conditions and with less fuss over toxic side products. I’ve come to appreciate the value of this difference, especially after seeing the cost and effort behind failed or contaminated syntheses.
Every researcher knows the frustration of buying a specialty chemical, only to discover the batch doesn’t live up to specs. With 1-(4-Bromophenyl)Piperazine, consistent quality counts for more than a marketing claim. Analytical testing—using HPLC and NMR—shows purity routinely above 98%. For a typical project, this means fewer unknowns. Spot impurities or side products, and the data starts drifting; keep purity high, and reproducibility improves. Having run several purification tracks myself, the difference shows up in every analysis sheet and in the reliability of downstream chemical steps.
Sourcing challenges pop up from time to time, especially as global supply chains shift. From experience, working with established suppliers pays off. Reputable producers don’t just test the end product—they document every stage, from raw materials to final lot analysis. That paper trail means more confidence at audit time and less risk of regulatory headaches down the line. Quality-conscious labs learn quickly that bargains evaporate once unreliable material sneaks into the process, and the headaches from chasing down a bad batch cost far more than any small savings on the front end.
Even the best products raise ethical questions, particularly where chemicals intersect with pharma and biological research. Nearly every molecule with central nervous system potential faces scrutiny because regulators closely monitor what goes into legitimate drug screening and what may divert into unsanctioned labs. 1-(4-Bromophenyl)Piperazine occupies a legal gray area in some countries—fully unrestricted in many, but flagged for special record-keeping in others. Staying compliant means more than obeying the letter of the law; it means knowing what documentation, tracking, and handling guidelines apply for research-grade materials. Failing to follow those rules can stall or end a promising program. Most institutions now require researchers to check current rules before ordering, and I’ve watched as major projects ground to a halt over overlooked regulatory hurdles.
On the ethical side, transparency counts for a lot. Chemistry departments, especially those with commercial interests, publish how and why they use specialty intermediates. This lets the public see how new therapies emerge and keeps academic researchers in good standing. In my experience, a clear record makes all the difference during funding reviews or publication, and more than once, open documentation has helped labs avoid accidental trouble by showing legitimate use.
Having the right chemical in hand sometimes makes or breaks a project. Those who’ve spent years doing benchtop synthesis know how small hiccups snowball—one unreliable intermediate can ruin weeks of work. A batch of 1-(4-Bromophenyl)Piperazine that matches published specs and arrives on time means reliable data, less repeat work, and more stable planning for grant proposals or industrial collaborations.
With modern research running on tight schedules and budgets, spending less time troubleshooting the basics frees up bandwidth for deeper investigation. I’ve watched colleagues switch suppliers after just a single bad batch caused weeks of troubleshooting. Every seasoned chemist shares stories about products that failed at the purification stage or generated confusing, unsortable blobs by TLC. Reliable piperazine derivatives rarely feature in those stories—well-made product gets used up fully, with satisfaction instead of regret.
High-quality chemicals rarely come cheap; budgets matter to research groups as much as to big pharma. Even so, price differences across suppliers aren’t always justified. Some charge a premium for traceability, some simply for name recognition, while others compete on actual quality. Lab managers face a tough balancing act—spend carefully, but avoid pitfalls of cutting corners. Having compared several suppliers side by side, the best results often come from seeking certifications, batch analytical data, and solid long-term relationships.
Bulk orders can bring prices down, though that only works for frequently used intermediates like 1-(4-Bromophenyl)Piperazine. Careful inventory and forecasting become practical answers for labs running regular screening programs. Working in pharma startups, I learned the value of pooling orders or contracting centralized procurement—a move that allowed us access to good stock at less painful prices. For smaller academic outfits, shared purchasing or departmental consortia create leverage where individual groups would struggle.
Another route involves building more robust relationships with suppliers, which can mean early warnings on shortages, reserved lots for essential projects, or expedited shipping in a pinch. Every time I see a panic request to the purchasing office, the contrast between “transactional“ vendors and collaborative partners stands out clearly.
No chemical—no matter how stable—deserves careless treatment. 1-(4-Bromophenyl)Piperazine handles moderately well without extra fuss, but the best results come from dry, room-temperature storage. Once the container is open, securely sealing it and keeping it out of direct sunlight preserves both product quality and safety. There’s never any benefit to taking shortcuts—one poorly stored reagent leads to poor results and can trigger unnecessary safety reviews. Most research spaces now incorporate dedicated flammables cabinets and keep close records of opened and unopened containers.
Beyond storage, proper labeling and routine checks prevent mix-ups—a lesson learned after catching a nearly disastrous swap between a methyl and a bromo analog during a late-night shift. Even experienced chemists sometimes slip. Double-checking chemical identity by NMR on new batches heads off these troubles, and most analytical labs worth their salt now treat this as a routine preliminary step.
Research evolves fast. In recent years, interest in designer molecules, targeted therapies, and novel materials surged. With its unique structure, 1-(4-Bromophenyl)Piperazine finds fresh uses in these expanding fields. Synthetic biologists, for instance, look for building blocks that offer both stability and reactivity—qualities this molecule embodies. I’ve noticed new publications highlight its utility in “click” chemistry, facilitating the assembly of modular systems or libraries for rapid drug screening.
Even those working outside classic pharmaceutical areas, such as environmental science or materials engineering, re-examine well-trodden chemical classes to meet modern demands. Whether it’s building dendritic polymers for advanced filtration or modifying surfaces for biosensor development, the ability to plug in a bromo-phenyl-piperazine scaffold extends possibilities without requiring brand-new synthetic routes.
Trust in chemical suppliers stems from more than marketing claims. Lab users judge by results—clean spectra, high yields, and trouble-free shipments. Suppliers that provide detailed certificates of analysis, comprehensive safety data, and full traceability earn repeat business, while those who skimp see customers disappear quickly. Building strong supplier relationships takes time but translates into smoother projects and fewer disasters.
One often overlooked factor in building trust is transparent support when things go wrong—mislabeling, shipping issues, or even rare contamination events. Responsive, helpful customer service saves entire projects and prevents unnecessary waste. Over time, both vendors and research teams build processes that prioritize safety, accountability, and clear communication. Every project that finishes on time and within budget, thanks to dependable chemicals, reinforces why these priorities matter.
As chemical research continues to reinvent itself, the need for adaptable, reliable, and well-characterized building blocks stays front and center. From my own experience across academic, industrial, and startup environments, 1-(4-Bromophenyl)Piperazine has quietly become a trusted tool. Its unique properties give scientists an edge when tackling tough challenges in synthesis, drug design, and advanced materials. Continued focus on quality, transparency, and thoughtful handling will keep this compound a staple in research and beyond. Modern science often advances at the edge of what’s possible, and reliable chemical allies make all the difference for those working to push that edge just a step further.
